Recombinant Human SPARC Protein, >98% (SDS-PAGE, HPLC), high purity

Features and benefits
  • Expression System: E.coli
  • Accession #: P09486
  • Protein Tag: No tag
  • Bioactivity: Fully biologically active when compared to standard. The ED50 as determined by its ability to inhibit the cell growth of Mv1Lu mink lung epithelial cells is less than 3.0 μg/mL, corresponding to a specific activity of > 333 IU/mg.
  • Endotoxin Concentration: <0.1 EU/μg
Item Number
rp151779
Grouped product items
SKUSizeAvailabilityPrice Qty
rp151779-10μg
10μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$79.90
rp151779-50μg
50μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$199.90
rp151779-100μg
100μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$379.90
rp151779-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,799.90

Animal Free, >98% (SDS-PAGE, HPLC), Active, E.coli, No tag, 18-303 aa

Basic Description

Product NameRecombinant Human SPARC Protein, >98% (SDS-PAGE, HPLC), high purity
SynonymsON | ONT | OI17 | BM-40 | Basement-membrane protein 40 | ONcysteine-rich protein | Osteonectin | Secreted protein acidic and rich in cysteine | secreted protein, acidic, cysteine-rich (osteonectin) | SPARC | AA517111 | Basement membrane protein 40 | BM 40
GradeActiBioPure™, Animal Free, Azide Free, Bioactive, Carrier Free, High Performance
Product Description

Purity
>98% by SDS-PAGE and HPLC analyses.

Function
Appears to regulate cell growth through interactions with the extracellular matrix and cytokines. Binds calcium and copper, several types of collagen, albumin, thrombospondin, PDGF and cell membranes. There are two calcium binding sites; an acidic domain that binds 5 to 8 Ca (2+) with a low affinity and an EF-hand loop that binds a Ca(2+) ion with a high affinity.

Specifications & PurityActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥98%(SDS-PAGE&HPLC)
Purity>98% (SDS-PAGE, HPLC)
BioactivityFully biologically active when compared to standard. The ED50 as determined by its ability to inhibit the cell growth of Mv1Lu mink lung epithelial cells is less than 3.0 μg/mL, corresponding to a specific activity of > 333 IU/mg.
Endotoxin Concentration<0.1 EU/μg
Expression SystemE.coli
SpeciesHuman
Amino Acids18-303 aa
Protein TagNo tag
Accession #P09486
Predicted molecular weight32.7 kDa
SDS-PAGE32.7 kDa
Note20μg卖完停产,不再备货

Images

Recombinant Human SPARC Protein (rp151779)-Protein Bioactivity
Fully biologically active when compared to standard. The ED₅₀ as determined by its ability to inhibit the cell growth of Mv1Lu mink lung epithelial cells is less than 3.0 μg/mL, corresponding to a specific activity of > 333 IU/mg.

Recombinant Human SPARC Protein (rp151779) - SDS-PAGE
Recombinant Human SPARC Protein was resolved with SDS-PAGE under reducing (R) and visualized by Coomassie® Blue staining. Showing a single band at 32.7 kDa.

Product Specifications

FormLyophilized
ReconstitutionWe recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportio
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconsti

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
ZJ23F0600329Certificate of AnalysisMar 26, 2024 rp151779
ZJ23F0600330Certificate of AnalysisMar 26, 2024 rp151779
ZJ23F0600331Certificate of AnalysisMar 26, 2024 rp151779

Related Documents

References

1. Kelm, R J RJ and Mann, K G KG..  (1990)  Human platelet osteonectin: release, surface expression, and partial characterization..  Blood,    (1):   [PMID:2306517]
2. Young, M F MF and 5 more authors..  (1990)  Structure and expression of osteonectin mRNA in human tissue..  Connective tissue research,      [PMID:2338025]
3. Villarreal, X C XC, Mann, K G KG and Long, G L GL..  (1989)  Structure of human osteonectin based upon analysis of cDNA and genomic sequences..  Biochemistry,    (25):   [PMID:2790009]
4. Swaroop, A A, Hogan, B L BL and Francke, U U..  (1988)  Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression, and localization of the gene to chromosome 5q31-q33..  Genomics,      [PMID:2838412]
5. Wewer, U M UM, Albrechtsen, R R, Fisher, L W LW, Young, M F MF and Termine, J D JD..  (1988)  Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane..  The American journal of pathology,      [PMID:3400777]
6. Lankat-Buttgereit, B B, Mann, K K, Deutzmann, R R, Timpl, R R and Krieg, T T..  (1988)  Cloning and complete amino acid sequences of human and murine basement membrane protein BM-40 (SPARC, osteonectin)..  FEBS letters,    (29):   [PMID:3410046]
7. Fisher, L W LW, Hawkins, G R GR, Tuross, N N and Termine, J D JD..  (1987)  Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone..  The Journal of biological chemistry,    (15):   [PMID:3597437]
8. Kuhn, C C and Mason, R J RJ..  (1995)  Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis..  The American journal of pathology,      [PMID:7495300]
9. Hohenester, E E and 5 more authors..  (1996)  Structure of a novel extracellular Ca(2+)-binding module in BM-40..  Nature structural biology,      [PMID:8548457]
10. Hohenester, E E, Maurer, P P and Timpl, R R..  (1997)  Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40..  The EMBO journal,    (1):   [PMID:9233787]
11. Hunzelmann, N N, Hafner, M M, Anders, S S, Krieg, T T and Nischt, R R..  (1998)  BM-40 (osteonectin, SPARC) is expressed both in the epidermal and in the dermal compartment of adult human skin..  The Journal of investigative dermatology,      [PMID:9457905]
12. Sasaki, T T, Hohenester, E E, Göhring, W W and Timpl, R R..  (1998)  Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin..  The EMBO journal,    (16):   [PMID:9501084]
13. Bechtel, Stephanie S and 18 more authors..  (2007)  The full-ORF clone resource of the German cDNA Consortium..  BMC genomics,    (31):   [PMID:17974005]
14. Mendoza-Londono, Roberto R and 20 more authors..  (2015)  Recessive osteogenesis imperfecta caused by missense mutations in SPARC..  American journal of human genetics,    (4):   [PMID:26027498]

Solution Calculators